98%
921
2 minutes
20
In the original article [...].
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706171 | PMC |
http://dx.doi.org/10.3390/toxics9120322 | DOI Listing |
Front Psychol
August 2025
Institute of Physical Education and Social Sciences, Shandong Sports University, Jinan, China.
[This corrects the article DOI: 10.3389/fpsyg.2025.
View Article and Find Full Text PDFFront Neurol
August 2025
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
[This corrects the article DOI: 10.3389/fneur.2024.
View Article and Find Full Text PDFPharmacogenet Genomics
September 2025
Department of Cardiology, Tengzhou Central People's Hospital, Tengzhou, Shandong.
Objectives: Dyslipidemia is a crucial risk factor for atherosclerotic cardiovascular disease. Although rosuvastatin is widely used, treatment response varies significantly due to genetic variation. This study investigated the pharmacogenomic impact of low-density lipoprotein receptor (LDLR) 3' untranslated region (UTR) variants on rosuvastatin efficacy in a Chinese Han adult cohort with dyslipidemia.
View Article and Find Full Text PDFFront Comput Neurosci
August 2025
Origin Dynamics Intelligent Robot Co., Ltd., Zhengzhou, China.
[This corrects the article DOI: 10.3389/fncom.2024.
View Article and Find Full Text PDF